Research graph
References from Nanomedicine and the tumor immune microenvironment in cancer immunotherapy: a bibliometric and knowledge-mapping analysis. Local targets link to admitted publications; unresolved targets remain external evidence.
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
10.3322/caac.21834 · 2024 · External reference
The cancer-immunity cycle: Indication, genotype, and immunotype
10.1016/j.immuni.2023.09.011 · 2023 · External reference
Cancer immune evasion, immunoediting and intratumour heterogeneity
10.1038/s41577-024-01111-8 · 2025 · External reference
Immune surveillance and immune escape in cancer: Mechanisms and immunotherapy
10.1002/mco2.70321 · 2025 · External reference
The tumor microenvironment's role in the response to immune checkpoint blockade
10.1038/s43018-025-00986-3 · 2025 · External reference
Immune cells within the tumor microenvironment: Biological functions and roles in cancer immunotherapy
10.1016/j.canlet.2019.11.009 · 2020 · External reference
Intratumoral microorganisms in tumors: Current understanding and emerging therapeutic strategies
10.1002/mco2.70754 · 2026 · External reference
Turning cold tumors into hot tumors to ignite immunotherapy
10.1186/s12943-025-02477-6 · 2025 · External reference
Cold and hot tumors: from molecular mechanisms to targeted therapy
10.1038/s41392-024-01979-x · 2024 · External reference
Exploiting innate immunity for cancer immunotherapy
10.1186/s12943-023-01885-w · 2023 · External reference
Integrative approaches to cancer immunotherapy
10.1016/j.trecan.2019.05.010 · 2019 · External reference
Neoantigens in cancer immunotherapy
10.1126/science.aaa4971 · 2015 · External reference
Understanding and treating the inflammatory adverse events of cancer immunotherapy
10.1016/j.cell.2021.02.011 · 2021 · External reference
Delivery strategies of cancer immunotherapy: recent advances and future perspectives
10.1186/s13045-019-0817-3 · 2019 · External reference
Immune evasion in cancer: mechanisms and cutting-edge therapeutic approaches
10.1038/s41392-025-02280-1 · 2025 · External reference
Nanomedicine tumor targeting
10.1002/adma.202312169 · 2024 · External reference
Stimuli-activatable nanomedicine meets cancer theranostics
10.7150/thno.87854 · 2023 · External reference
Tumor-targeted nanomedicine for immunotherapy
10.1021/acs.accounts.0c00518 · 2020 · External reference
Nanomaterials for cancer therapy: current progress and perspectives
10.1186/s13045-021-01096-0 · 2021 · External reference
Nanobodies targeting the tumor microenvironment and their formulation as nanomedicines
10.1186/s12943-025-02270-5 · 2025 · External reference
Tumor microenvironment-derived exosomes: A double-edged sword for advanced T cell-based immunotherapy
10.1021/acsnano.4c09190 · 2024 · External reference
Analysis of nanoparticle delivery to tumours
10.1038/natrevmats.2016.14 · 2016 · External reference
A translational framework to DELIVER nanomedicines to the clinic
10.1038/s41565-024-01754-7 · 2024 · External reference
Tumor microenvironment-responsive nanomedicines for potentiating cancer immunotherapy
10.1002/advs.202513567 · 2025 · External reference
CiteSpace II: detecting and visualizing emerging trends and transient patterns in scientific literature
10.1002/asi.20317 · 2006 · External reference
Nano-assisted dynamically assembled hydrogels with strong tissue adhesion and proactive immunomodulation for bone defect repair
10.1016/j.bioactmat.2025.07.038 · 2025 · External reference
Tumor microenvironment responsive nano-immunoregulator for precision cancer photodynamic immunotherapy
10.1016/j.mtbio.2026.103162 · 2026 · External reference
Dual-targeting mRNA cancer vaccines for simultaneous antigen presentation in dendritic and tumor cells
10.1021/acsnano.5c20535 · 2026 · External reference
Nano based drug delivery systems: recent developments and future prospects
10.1186/s12951-018-0392-8 · 2018 · External reference
Emerging advantages of nano delivery systems in enhancing CAR-T/CRISPR-Cas9 mediated cancer therapeutics
10.1016/j.bbcan.2026.189592 · 2026 · External reference
Opportunities and challenges for co-delivery nanomedicines based on combination of phytochemicals with chemotherapeutic drugs in cancer treatment
10.1016/j.addr.2022.114445 · 2022 · External reference
Advances in multiple stimuli-responsive drug-delivery systems for cancer therapy
10.2147/ijn.s293427 · 2021 · External reference
Nano-omics and nanomedicine target microbial carcinogenesis: Tumor microenvironment reprograming to clinical translation
10.1016/j.critrevonc.2025.104866 · 2025 · External reference
Next-generation nanomotors: a biomedical platform for precision tumor targeting and treatment
10.1021/acsnano.5c15117 · 2026 · External reference
An intracellular gelated macrophage-based vaccine for tumor immunotherapy
10.1021/acsnano.5c17200 · 2026 · External reference
Reprogramming immunosuppressive niches and the cancer immunity cycle in pancreatic cancer with neoantigen mRNA plus immune adjuvant nanocarrier strategies
10.1021/acsnano.5c14753 · 2025 · External reference
Selective membrane protein enrichment enables defined biomimetic nanoparticles for endothelial targeting
10.1002/smll.202513548 · 2026 · External reference
Remodeling the tumor microenvironment: An emerging paradigm for reinvigorating immunologically cold tumors and advancing cancer immunotherapy
10.1021/acsnano.5c14644 · 2026 · External reference
Immune-modulating dual-targeted nanomaterials for low-temperature photothermal-photodynamic-chemodynamic therapy of osteosarcoma targeting tumor and endothelial cells
10.1021/acsnano.5c00223 · 2025 · External reference
Cancer cell membrane-coated homodimer prodrug nanoassemblies to simultaneously deliver prodrugs and immune adjuvants for combined chemo-immunotherapy
10.1021/acsnano.5c06202 · 2025 · External reference
Macrophage-membrane-engineered NIR II biomimetic nanomaterials for enhanced synergistic chemo-photothermal immunotherapy in cancer treatment
10.1016/j.colsurfb.2025.114759 · 2025 · External reference
Harnessing smart nanomaterials to reprogram neutrophil plasticity in immune modulation
10.1186/s12951-025-03740-0 · 2025 · External reference
Nano-immune-engineering approaches to advance cancer immunotherapy: Lessons from ultra-pH-sensitive nanoparticles
10.1021/acs.accounts.0c00475 · 2020 · External reference
The landscape of nanoparticle-based siRNA delivery and therapeutic development
10.1016/j.ymthe.2024.01.005 · 2024 · External reference
Lipid nanoparticle technology for clinical translation of siRNA therapeutics
10.1021/acs.accounts.9b00368 · 2019 · External reference
Lipid nanoparticles (LNPs) for in vivo RNA delivery and their breakthrough technology for future applications
10.1016/j.addr.2023.114990 · 2023 · External reference
Controlling the biodistribution and clearance of nanomedicines
10.1038/s44222-023-00138-1 · 2024 · External reference
The mechanisms of nanoparticle delivery to solid tumours
10.1038/s44222-024-00154-9 · 2024 · External reference
Progress and challenges in the translation of cancer nanomedicines
10.1016/j.copbio.2023.103045 · 2024 · External reference
